Dr. Leath Discusses Surgical Cytoreduction in Ovarian Cancer

In Partnership With:

Partner | Cancer Centers | <b>O’Neal Comprehensive Cancer Center at the University of Alabama at Birmingham</b>

Charles A. (Trey) Leath, III, MD, associate professor, UAB School of Medicine, UAB Comprehensive Cancer Center, discusses surgical cytoreduction in ovarian cancer.

Charles A. (Trey) Leath, III, MD, associate professor, UAB School of Medicine, UAB Comprehensive Cancer Center, discusses surgical cytoreduction in ovarian cancer.

With recently emerging data, oncologists are better equipped to identify patients who do not need primary cytroreduction. Additionally, Leath says that oncologists now know what to do—and what not to do—at the time of surgery for their patients with ovarian cancer.